Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Comprehensive Cholesterol Tests Provides Clues for Metabolic Abnormality

By LabMedica International staff writers
Posted on 20 Sep 2010
A detailed lipid profile is helping physicians to diagnose Polycystic Ovarian Syndrome (PCOS), the number one cause of female infertility. More...


The comprehensive cholesterol panel known as the Vertical Auto Profile (VAP) measures 15 separate components of blood cholesterol and can identify a far greater number of lipid abnormalities than standard low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol, and triglycerides.

The VAP test is the only cholesterol test to identify markers for Metabolic Syndrome, a precursor for diabetes. The VAP extended lipid test was developed by Atherotech Diagnostics, (Birmingham, AL, USA) and can report 22 blood "cholesterol” components including accurate measurement of nonfasting direct LDL and all the lipoprotein subclasses.

PCOS increases the risk of heart disease, insulin resistance, diabetes and certain cancers. It is also the most common metabolic abnormality in women of childbearing age, affecting 5-10 million women nationwide. While there is no single test for diagnosing the illness, the detailed cholesterol profile is proving useful. The four major symptoms of PCOS are irregular periods, weight gain, high testosterone levels, and metabolic disorders, including abnormal cholesterol levels. Results have shown a correlation between patients who have PCOS and high levels of total cholesterol and triglycerides, but low levels of high-density lipoprotein 2, a highly protective subclass of HDL.

Steven Foley, M.D., a physician who specializes in PCOS, said, "It is the most accurate and easiest method to evaluate my female patients for elevated cholesterol as well as polycystic ovarian syndrome. It is particularly valuable when developing a treatment plan for women and also helps to monitor response to treatment."

Related Links:

Atherotech




New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.